What's New in Health and Life Sciences

News from the European Comission

EUROPA - Research and Innovation: Health & Life Sciences

EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health web site. For more RSS news feeds visit
For more RSS news feeds click the link above.
ImageAfter cardiovascular diseases, cancer is the second leading cause of death and morbidity in European countries and is one of the most significant health challenges worldwide. An EU-funded project is developing new tools for diagnosing cancer and for understanding the role of proteins in this and other major diseases.

The European Commission's Scientific Panel for Health (SPH) is a science-led expert group based on the provisions of the Horizon 2020 Specific Programme, which is tasked with helping to achieve better health and wellbeing for all.

The Panel’s main roles are to provide foresight and overall vision and strategy, as well as, to identify bottlenecks to innovation and propose solutions in the area of health and biomedical research.

Based on interactions with stakeholders during conferences and workshops, the Scientific Panel for Health set out a vision for the future of health and biomedical research in two consensus documents: ‘Better Research for Better Health’ in 2016, and a proposal ‘Building the Future of Health Research’ in 2018. Both documents are available through the SPH website.

From further stakeholders’ consultation important topics were identified that will be the focus of the next forum to be organized with the European Commission on May 6, 2019 in Brussels: ‘Enabling health equality in Europe – the role of health research’.

The forum explores the current situation, barriers in participation and engagement with health research, and ways forward.

The SPH wishes to build an ambitious future for health research in Europe.

The forum with the European Commission is an opportunity to participate in the debate to which you are warmly invited.

The full program will be published shortly, but please, already save the date in your agenda.

ImageAn EU-funded project is developing software, based on artificial intelligence, that enables robots to more effectively interact with autistic children in human-led therapy sessions, helping to improve their social and communication skills.
Antimicrobial resistance (AMR) is directly linked to sanitary conditions and the population’s general state of health: the better the sanitation, the lower the problem of AMR.
ImageEuropean science is missing out on talent as leadership positions remain predominantly occupied by men. To challenge this gender imbalance, an EU-funded project is helping research institutes support female staff in their research career and encouraging work-life balance.
ImageAn EU and industry-funded project has developed new patient-centred tools and approaches to help people with chronic obstructive respiratory disease (CODP) get more personalised treatments - a means to boost their activity levels, health and well-being.

This year’s event is entitled "Forward as one: Healthcare Innovation and the need for policymaker engagement", and will be held in association with the Romanian Presidency of the European Union, which runs until the end of June.

More than ever before, in this crucially important year, the EAPM Conference will allow for a bridge to national representatives is order to further build on the developments that the Alliance has helped to architect in various policy areas.

It is the ideal one-stop shop, as stakeholders from every discipline and every Member State come together to forge the way ahead.

Key topics to be discussed in Brussels will include:

    • Personalised Medicine and the Innovation Agenda: An Integrated Approach • Technology Developments • Hematology • Personalised Treatments and Personalised Prevention • Pharmaceutical/Diagnostics • The Regulatory Framework (Part I) • Pharmaceutical/Diagnostics • The Regulatory Framework (Part II) • Political Will and Institutional Support
ImageLong-term vision, high-level endorsement and participation, and tailored forms of international scientific collaboration are key to overcoming widespread fragmentation and improving service quality 'and' health outcomes in Latin America. This is the overriding conclusion of an international research team backed by the European Union.
ImagePeptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.


PRONIA Workpackages

For Help-seekers and Relatives

For Help-seekers and Relatives Für Hilfesuchende und Angehörige
Per Pazienti e Parenti Potilaille ja Omaisille

Newsletter Subscription

Please fill in the information of your subscription.


News Section

No news available.

Press Area

+++ Information about PRONIA for the Press and Press Events +++

+++ Latest PRONIA Publications +++